We start 2022 with a strong first quarter, where sales increased by 49 percent to SEK 2,579 million and EBITA increased by 34 percent to SEK 435 million, resulting in an EBITA margin of 16.9 percent. This growth comes mainly from our acquisitions and the strong expansion in Europe in recent years.
AddLife has today donated medical devices for critical care to Ukraine at an approximated amount of SEK 7 million. The donation has been made in coordination with the Ukraine embassy in Stockholm and Ukraine Ministry of Foreign Affairs to meet specified needs from their health department.
The products are currently being transported to the border between Poland and Ukraine. The initiative is a collaboration between the group companies Mediplast (Sweden) and Healthcare 21 (UK & Ireland) with support from Biomedica Medizinprodukte´s (Austria) local office in Poland.
We want to recognize the strong engagement and extra work by our employees for making this initiative happen.
Labtech offers products, solutions and a broad range of services in diagnostics, biomedical research and laboratory analysis.
MORE ABOUT LABTECHMedtech offers products, solutions and services in medtech and home care.
MORE ABOUT MEDTECHWe develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.
MORE ABOUT AQUISITIONS
AddLife´s business concept is to provide added value to its customers who are active in the healthcare sector – from research to medical care. This is done by offering high-quality, cost-effective solutions of services and products to both the private and public sectors in Europe.
MORE ABOUT ADDLIFE
